12 Jul
Stem cells have been making headlines for the past three decades for good reason – they are master cells, capable of generating nearly any specialised cell in the human body. Our ability to manipulate and replicate these cells holds tremendous hope for regenerative medicine, to test the safety and effectiveness of treatments, and understand […]
READ MORE8 Mar
Hadassah Cancer Research Institute at the Hadassah University Hospital in Jerusalem, announced last month that researchers have designed a genomic analysis tool for cancer patients that enables advanced selection of drugs targeting schemes for cancer genes, opening the door to improved personalised medicine in cancer treatment. The science behind this breakthrough tool is a […]
READ MORE16 Feb
Breakthrough research at Hadassah identifies all possible cancer-causing mutations of a key gene (TP53) found in 50% of tumours. The Hadassah Cancer Research Institute at the Hadassah University Medical Centre in Jerusalem, announced today that using artificial intelligence (AI), researchers have developed, an algorithm to identify, with an unprecedented 96.5% level of accuracy, all possible deleterious […]
READ MORE12 Jan
Classically, researchers in basic medical science have had two tools: in vitro cultures and animal models. The limitations pose many challenges: Cells taken out of the human body and grown in a petri dish won’t behave exactly as they do within a real organ of the body. Animal models are not as highly complex as the human body. […]
READ MORE17 Dec
A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof. […]
READ MORE10 Jul
Just six months have passed since the Wohl Institute for Translational Medicine opened at Hadassah Hospital Ein Kerem, but it has already become the focus of 30 research projects from Hadassah. “In such a short time, with nearly half of it dominated by COVID-19, we’ve established ourselves as a national centre,” says Institute Director Prof. […]
READ MORE21 Jan
Edited from an article in The Times, 17 January 2020. Thanks to AI and genome editing, age-defying treatment breakthroughs that were just out of our reach should become reality, says Tom Whipple. In the next ten years medicine will get cleverer, more targeted and personalised. But what is personalised medicine? Experimental genetic therapies find their way […]
READ MORE9 Jan
Hadassah Medical Centre in Jerusalem, a leader in the field of molecular diagnosis of tumours, has announced that its Molecular Pathology and Diagnostic Tumours department is now the first location in the Middle East and third outside of the United States to conduct a unique tumour diagnostic test within its own laboratories that help inform […]
READ MORE19 Dec
The International Society for Affective Disorders (ISAD) has honoured the Hadassah Medical Centre’s pioneering psychiatrist Prof. Bernard Lerer with its first-ever Lifetime Achievement Award. Prof. Lerer, 71, was born in South Africa and moved to Israel as a young physician. He entered the field of psychiatry just after the revolutionary anti-psychotic and anti-depressant drugs like […]
READ MORE18 Nov
Prof. Rivka Dresner Pollak, head of the Hadassah Medical Organisation’s Department of Endocrinology and Metabolism, together with University of Oxford colleague Prof. Lynne Cox, has received funding for a three-year joint project to study age-related bone fragility in patients with type 1 diabetes who are currently at high risk of bone fracture and premature death, […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK